Berczi, CsabaHadjievangelou, Charalambos2020-02-242020-02-242019-06-06http://hdl.handle.net/2437/281210Prostate cancer remains one of the major global health burdens, as it represents the second cause of cancer and the fifth leading cause of cancer-related death worldwide.The detection of PC is nowadays accomplished by prostate MRI and MRI-US fusion targeted biopsy, with the ultimate goal of reducing detection rates of clinically insignificant disease, increasing detection rates of clinically significant cancer, and better assessing disease size, grade, and location. Valuable information about the histopathological aggressiveness of a lesion can be provided with Multiparametric MRI, as well as the stage of a tumor with possible Ectracapsular extension can be assessed.MRI can aid patient selection for Active Surveillance, and therefore decrease misclassification rates, expand criteria to increase enrollment and limit the invasive follow-up nature of Active Surveillance.32enMRIprostatecarcinomaDEENK Témalista::Orvostudomány